BostonSight is closing its lab and consultation services on Monday, September 7th, 2026.
Published
Signal category
Operations & Supply
Quote
“BostonSight, including lab and consultation, will be closed on Monday, September 7th, 2026”
— BostonSight team
Company
BostonSight
Nonprofit advancing specialty lens care in service of patients and the professionals who care for them.
- Industry
- Hospitals and Health Care
- Location
- Needham, US
- Company size
- 58 employees
BostonSight is a nonprofit healthcare organization that advances the treatment of diseased and damaged corneas and dry eye. We work toward optimal patient outcomes through compassionate care, innovative scleral lens design, education, and technology. PROSE® is our medical treatment for the most severe or challenging ocular surface disease cases and delivered via highly trained eye care professionals at top tertiary eye centers. BostonSight SCLERAL® is our commercially available scleral lens used by optometrists worldwide. BostonSight SCLERAL provides diagnostic lens and free form fitting options with a range of diameters and features to simplify scleral lens fitting. BostonSight SCLERAL is effective for simple to more advanced ocular surface disease cases. Learn more at www.bostonsight.org and www.bostonsightscleral.org
Founded 1992